RxDoctor Payments Data

Teresa Nasabzadeh, MD

Dermatology · Alexandria, VANPI 1376860783

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.7% of the total across 960 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 41 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. Among dermatology clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,632in general payments, 2019–2025

Across 960 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Johnson & Johnson$2K
  • Sanofi$1K
  • E.r. Squibb & Sons, L.L.C.$1K
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$1K
  • Lilly USA, LLC$1K
  • plus $9K from 35 others

What the payments were for

  • Food & beverage$17,40399%
  • Education$2291%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,632 in reported general payments places this provider in the 90th percentile of 396 dermatology providers in Virginia.

See all dermatology providers in Virginia

Medicare billing

Part B allowed, 2024
$121,600
Medicare patients
295
Services billed
1,733

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab12$44,631
JubliaEfinaconazole11$9,199
Pimecrolimus14$3,635
Tacrolimus17$2,250
Clobetasol Propionate31$2,081
Ciclopirox34$1,979
Fluocinonide39$1,728
Fluorouracil22$1,512
Tretinoin41$1,483
Ketoconazole106$1,446
Triamcinolone Acetonide83$852
Clindamycin Phosphate28$826
Doxycycline Hyclate36$735
Mometasone Furoate28$561
Mupirocin66$540

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia$1,031$9,19911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 396 dermatology providers in Virginia.

Other dermatology in Alexandria

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →